Čezmejni pretvornik
PKD 2025 21.10 → ekvivalent NACE Rev 2.1 (Cyprus)
Nacionalna klasifikacija dejavnosti Poland (PKD 2025) deli svojo 4-mestno strukturo s standardom EU NACE Rev 2.1. Na tej podlagi prikažemo ekvivalentni podrazred(e) NACE Rev 2.1, ki se uporablja v Cyprus.
Skupni nadrejeni razred EU
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Produkcja podstawowych substancji farmaceutycznych
21.10
Manufacture of basic pharmaceutical products
O tej pretvorbi
PKD 2025 je klasifikacija dejavnosti, ki se uporablja v Poland. NACE Rev 2.1 je ekvivalentni sistem v Cyprus. Oba sta nacionalni izvedbi EU NACE Rev 2.1, zato lahko kateri koli 5-mestni podrazred v enem sistemu izsledite nazaj do skupnega 4-mestnega EU razreda — in od tam projicirate v podrazrede druge države.
Ta stran je ustvarjena za poizvedbo »PKD 2025 21.10 v NACE Rev 2.1« in ostaja sinhronizirana z našo mesečno sinhronizacijo Market Intelligence.